Get In Touch


NOVEL Health Strategies' Principal and Co-Founder Saurabh (Rob) Aggarwal, PhD is presenting at upcoming specialty pharmacy continued medical education conference on Biosimilars.

This presentation will cover topics on challenges and opportunities for Biosimilars.

Challenges Hindering Advancement & Approvals of Biosimilars in the United States

  • Describe challenges facing implementation of Biosimilars

  • Describe how to overcome licensing and price competition

  • Describe strategies for formulary decisions relative to biosimilar market


  • Discuss the challenges of Naming conventions in advancing Biosimilars in

    the US

  • Describe the impact of administration devices with biosimilars - and the

    patents owned by the innovator, i.e. auto- injectors.

  • Review the utilization of 'white-bagging' for biosimilars




With the first biosimilar product approved by the FDA in the United States and more on the horizon, there is no better time to discuss the future, growth, and implications with leading companies and executives in the industry. The changes are coming rapidly and many issues have yet to be addressed, including interchangeability, cost burden, state and federal regulations, commercialization, 'white-bagging' utilization and the role of health information technology.

With multi-stakeholder sessions and presentations by key players and decision-makers, Biosimilars 20/20 is the industry event of the summer!

Strategy Overview on Breakthrough Therapy Designations (Nature Biotech, April 2014)

NOVEL just published a comprehensive overview on all Breakthrough Therapy Designated products, covering their clinical, HEOR, comparative effectiveness and market access.

Read More

NOVEL Won Two Platinum Medal Awards at AMCP

NOVEL's team won two Platinum Medal Awards for Presentations at AMCP Nexus Educational Conference in Boston.

Read More

Nineteen Presentations at ISPOR 2013 New Orleans

NOVEL's team presented nineteen studies on HEOR and market access trends at the 18th Annual International ISPOR meeting in New Orleans.

Read More

Podium & Poster Presentations at HTAi 2013 Seoul, Korea

At the Health Technology Assessment HTAi Annual 2013 Meeting in Seoul, Korea, NOVEL's team was selected for podium and poster presentations.

Read More

Annual Strategy Perspective in Nature Biotechnology

Our annual strategy series has been cited and quoted more than two hundred times. JUST PUBLISHED latest article in January 2014 issue.

Read More

Market Access & Reimbursement Strategy Seminar in Copenhagen

NOVEL's team and leading healthcare stakeholders hosted a one-day workshop on Market Access & Reimbursement Strategy in Copenhagen (Ministry of Foreign Affairs, Denmark).

Read More